复合物索波拉可以通过抑制cGAS调节巨细胞极化来缓解性结肠炎:网络药理学和实验验证
Fei Gao1, Shuangjiao Deng1, Yujin Liu1
1Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Aging
|April 13, 2024
概括
复合物Sophora开 (CSD) 通过抑制cGAS来治疗性结肠炎 (UC),该药物可以调节巨细胞的两极分化. 这项研究确定了CSD.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种具有挑战性的炎症性肠病,其病因不明.
- 传统的药物,如复合索波拉 (CSD) 显示UC治疗的潜力,但他们的机制需要阐明.
研究的目的:
- 通过网络药理学和实验验验证,研究复合索波拉 (CSD) 在性结肠炎 (UC) 中的治疗和机制.
- 确定UC治疗中CSD的新型治疗点.
主要方法:
- 网络药理学方法用于预测UC的CSD组件和目标.
- 在体外和体内实验中使用细胞系 (Raw 264.7,BMDMs) 和硫酸 (DSS) 诱导的UC小鼠模型.
- 流细胞计,基因表达分析 (mRNA) 和蛋白质分析,以评估巨细胞两极分化和炎症标志物.
主要成果:
- 在UC中确定了155个潜在的CSD点,其中氧化合成酶 (NOS2/iNOS) 与巨细胞两极化有关.
- 证实CSD治疗抑制cGAS (干扰素基因刺激器) 表达,并减少炎症因素 (CCL17,IL10,TNF-α,CXCL10).
- 证明了CSD调节巨分极 (iNOS和Arg1) 的能力,并减轻DSS诱导的UC病理.
结论:
- 复合物索波拉开 (CSD) 通过抑制cGAS缓解硫酸 (DSS) 诱导的性结肠炎 (UC).
- CSD有效调节巨细胞两极分化,为UC提供潜在的治疗策略.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Drugs for Treatment of Constipation-Predominant IBS
161
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
161
Drugs for Treatment of Diarrhea-Predominant IBS
163
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
163
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145


